FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Mancuso A, Daikhin E, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A. 2007;104(49):19345–19350.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Cheng T. Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29(3):313–324.
   PubMed Web of Science ®Google Scholar
• Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr. 1995;15(1):133–159.
   PubMedGoogle Scholar
• Katt WP, Lukey MJ, Cerione RA. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis. Future Med Chem. 2017;9(2):223–243.
   PubMed Web of Science ®Google Scholar
• Szeliga M, Bogacinska-Karas M, Rozycka A, et al. Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells. Tumour Biol. 2014;35(3):1855–1862.
   PubMedGoogle Scholar
• Elgadi KM, Meguid RA, Qian M, et al. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics. 1999;1(2):51–62.
   PubMed Web of Science ®Google Scholar
• Szeliga M, Matyja E, Obara M, et al. Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors. Neurochem Res. 2008;33(5):808–813.
   PubMedGoogle Scholar
• Turner A, McGivan JD. Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem J. 2003;370(Pt 2):403–408.
   PubMedGoogle Scholar
• Han T, Zhan W, Gan M, et al. Phosphorylation of glutaminase by PKCepsilon is essential for its enzymatic activity and critically contributes to tumorigenesis. Cell Res. 2018;28(6):655–669.
   PubMed Web of Science ®Google Scholar
• Wang JB, Erickson JW, Fuji R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 2010;18(3):207–219.
   PubMed Web of Science ®Google Scholar
• Han T, Guo M, Zhang T, et al. A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway. Oncotarget. 2017;8(17):28063–28073.
   PubMedGoogle Scholar
• Wang Z, Liu F, Fan N, et al. Targeting glutaminolysis: new perspectives to understand cancer development and novel strategies for potential target therapies. Front Oncol. 2020;10:589508.
   PubMed Web of Science ®Google Scholar
• Gao P, Tchernyshyov I, Chang TC, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458(7239):762–765.
   PubMed Web of Science ®Google Scholar
• Lukey MJ, Greene KS, Erickson JW, et al. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy. Nat Commun. 2016;7(1):11321.
   PubMedGoogle Scholar
• Greene KS, Lukey MJ, Wang X, et al. SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis. Proc Natl Acad Sci U S A. 2019;116(52):26625–26632.
   PubMed Web of Science ®Google Scholar
• van den Heuvel AP, Jing J, Wooster RF, et al. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol Ther. 2012;13(12):1185–1194.
   PubMed Web of Science ®Google Scholar
• Sellers K, Fox MP, Bousamra M 2nd, et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Invest. 2015;125(2):687–698.
   PubMed Web of Science ®Google Scholar
• Godfrey S, Kuhlenschmidt T, Curthoys P. Correlation between activation and dimer formation of rat renal phosphate-dependent glutaminase. J Biol Chem. 1977;252(6):1927–1931.
   PubMedGoogle Scholar
• Morehouse RF, Curthoys NP. Properties of rat renal phosphate-dependent glutaminase coupled to Sepharose. Evidence that dimerization is essential for activation. Biochem J. 1981;193(3):709–716.
   PubMedGoogle Scholar
• Ferreira AP, Cassago A, Goncalves Kde A, et al. Active glutaminase C self-assembles into a supratetrameric oligomer that can be disrupted by an allosteric inhibitor. J Biol Chem. 2013;288(39):28009–28020.
   PubMed Web of Science ®Google Scholar
• McDonald CJ, Acheff E, Kennedy R, et al. Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase. Neurochem Int. 2015;88:10–14.
   PubMedGoogle Scholar
• Schneider TJ, Fischer GM, Donohoe TJ, et al. A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J Exp Med. 1999;189(6):949–956.
   PubMed Web of Science ®Google Scholar
• Huo J, Xu S, Guo K, et al. Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes. Cell Death Differ. 2009;16(7):1062–1070.
   PubMedGoogle Scholar
• Moubarak RS, Planells-Ferrer L, Urresti J, et al. FAIM-L is an IAP-binding protein that inhibits XIAP ubiquitinylation and protects from Fas-induced apoptosis. J Neurosci. 2013;33(49):19262–19275.
   PubMed Web of Science ®Google Scholar
• Martinez-Marmol R, Barneda-Zahonero B, Soto D, et al. FAIM-L regulation of XIAP degradation modulates synaptic long-term depression and axon degeneration. Sci Rep. 2016;6(1):35775.
   PubMedGoogle Scholar
• Malumbres M, Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem Sci. 2005;30(11):630–641.
   PubMed Web of Science ®Google Scholar
• Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11(3):1566–1572.
   PubMed Web of Science ®Google Scholar
• Winslow MM, Dayton TL, Verhaak RG, et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 2011;473(7345):101–104.
   PubMedGoogle Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021;17(1):1–382.
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, et al. mTOR regulation of autophagy. FEBS Lett. 2010;584(7):1287–1295.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Duran RV, Oppliger W, Robitaille AM, et al. Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell. 2012;47(3):349–358.
   PubMedGoogle Scholar
• Plaitakis A, Kalef-Ezra E, Kotzamani D, et al. The glutamate dehydrogenase pathway and its roles in cell and tissue biology in health and disease. Biology (Basel). 2017;6(1):11.
   PubMedGoogle Scholar
• Deshwal S, Fiedler KU, Langer T. Mitochondrial proteases: multifaceted regulators of mitochondrial plasticity. Annu Rev Biochem. 2020;89(1):501–528.
   PubMedGoogle Scholar
• Kita K, Suzuki T, Ochi T. Diphenylarsinic acid promotes degradation of glutaminase C by mitochondrial Lon protease. J Biol Chem. 2012;287(22):18163–18172.
   PubMedGoogle Scholar
• Nouri K, Feng Y, Schimmer AD. Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy. Cell Death Dis. 2020;11(10):841.
   PubMed Web of Science ®Google Scholar
• Huo J, Ma Y, Liu JJ, et al. Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis. Cell Death Dis. 2016;7:e2091.
   PubMedGoogle Scholar
• Carriba P, Comella JX. Amyloid Beta, TNFalpha and FAIM-L; approaching new therapeutic strategies for AD. Front Neurol. 2014;5:276.
   PubMed Web of Science ®Google Scholar
• Carriba P, Jimenez S, Navarro V, et al. Amyloid-beta reduces the expression of neuronal FAIM-L, thereby shifting the inflammatory response mediated by TNFalpha from neuronal protection to death. Cell Death Dis. 2015;6:e1639.
   PubMed Web of Science ®Google Scholar
• Wang P, Xun W, Han T, et al. FAIM-S functions as a negative regulator of NF-kappaB pathway and blocks cell cycle progression in NSCLC cells. Cell Cycle. 2020;19(24):3458–3467.
   PubMed Web of Science ®Google Scholar
• Huo J, Xu S, Lin B, et al. Fas apoptosis inhibitory molecule is upregulated by IGF-1 signaling and modulates Akt activation and IRF4 expression in multiple myeloma. Leukemia. 2013;27(5):1165–1171.
   PubMed Web of Science ®Google Scholar
• Xiao X, Qiu P, Gong HZ, et al. PACAP ameliorates hepatic metabolism and inflammation through up-regulating FAIM in obesity. J Cell Mol Med. 2019;23(9):5970–5980.
   PubMedGoogle Scholar
• Huo J, Xu S, Lam KP. Fas apoptosis inhibitory molecule regulates T cell receptor-mediated apoptosis of thymocytes by modulating Akt activation and Nur77 expression. J Biol Chem. 2010;285(16):11827–11835.
   PubMedGoogle Scholar
• Polletta L, Vernucci E, Carnevale I, et al. SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy. 2015;11(2):253–270.
   PubMed Web of Science ®Google Scholar
• Cheong H, Lindsten T, Wu J, et al. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A. 2011;108(27):11121–11126.
   PubMed Web of Science ®Google Scholar
• Qie S, Chu C, Li W, et al. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation. J Cell Biochem. 2014;115(3):498–509.
   PubMed Web of Science ®Google Scholar
• Colombo SL, Palacios-Callender M, Frakich N, et al. Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes. Proc Natl Acad Sci U S A. 2010;107(44):18868–18873.
   PubMed Web of Science ®Google Scholar
• Haynes CM, Petrova K, Benedetti C, et al. ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev Cell. 2007;13(4):467–480.
   PubMedGoogle Scholar
• Kaku H, Ludlow AV, Gutknecht MF, et al. FAIM opposes aggregation of mutant SOD1 that typifies some forms of familial amyotrophic lateral sclerosis. Front Neurosci. 2020;14:110.
   PubMedGoogle Scholar
• Uranishi M, Iida S, Sanda T, et al. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy. Leukemia. 2005;19(8):1471–1478.
   PubMedGoogle Scholar
• Coccia E, Masanas M, Lopez-Soriano J, et al. FAIM is regulated by MiR-206, MiR-1-3p and MiR-133b. Front Cell Dev Biol. 2020;8:584606.
   PubMedGoogle Scholar
• MacKenzie ED, Selak MA, Tennant DA, et al. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol. 2007;27(9):3282–3289.
   PubMed Web of Science ®Google Scholar